Castleman Disease Treatment Market Analysis: Emerging Therapies and Forecast
The Castleman Disease Treatment Market is expected to benefit from growing investment in rare-disease research and the development of innovative therapeutic technologies. The market was valued at approximately USD 600 million in 2025 and is forecast to reach USD 1 billion by 2035. One major opportunity is the development of biologic therapies. Targeted treatments such as monoclonal antibodies...
0 Comments 0 Shares 119 Views 0 Reviews